MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
CASI Pharmaceuticals, Inc. Ordinary Shares

CASI

#3957
CASI Pharmaceuticals, Inc. Ordinary Shares
0.21
-73.75%
Sector:
Base:
Profit Currency:
Daily Range
0.21
0.21
Year Range
0.21
3.08
Daily Change
-73.75%
Monthly Change
-78.79%
6 month change
-90.41%
Year Change
-91.36%
Previous Close
0.80
Open
0.21
Bid
Ask
Low
0.21
High
0.21
Volume
17
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. CASI
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202220232024 TTM

News

Benzinga Benzinga
CASI
2 days ago, 03:03
What Drove CASI Pharmaceuticals' 24% Rise After Hours? - CASI Pharmaceuticals (NASDAQ:CASI)
Investing Investing
UNH IBM CRM HD SHW
2026.02.25
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%
Investing Investing
CASI
2026.02.25
CASI Pharmaceuticals stock plunges on Nasdaq delisting notice
Zacks Zacks
ALKS CASI
2026.02.02
Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year?
Zacks Zacks
ALKS CASI
2026.01.15
Are Medical Stocks Lagging Alkermes (ALKS) This Year?
Investing Investing
CASI
2026.01.15
China approves CASI Pharmaceuticals’ CID-103 clinical trial for kidney rejection
Investing Investing
CASI
2025.12.23
CASI Pharmaceuticals stock surges after Nasdaq grants listing extension
Investing Investing
CASI
2025.12.23
Casi Pharmaceuticals secures Nasdaq listing extension until February 2026
Investing Investing
CASI
2025.12.11
CASI Pharmaceuticals secures $20 million funding for transplant rejection study
Investing Investing
CASI
2025.12.08
CASI Pharmaceuticals reports positive phase 1 data for ITP treatment
Investing Investing
CASI
2025.11.10
CASI Pharmaceuticals faces Nasdaq delisting over market value requirement
Investing Investing
CASI
2025.09.26
James Huang to join CASI Pharmaceuticals board as independent director

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd